Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-6 of 6 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2017Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancerPonnusamy, S.; Coss, C.; Thiyagarajan, T.; Watts, K.; Hwang, D.-J.; He, Y.; Selth, L.; McEwan, I.; Duke, C.; Pagadala, J.; Singh, G.; Wake, R.; Ledbetter, C.; Tilley, W.; Moldoveanu, T.; Dalton, J.; Miller, D.; Narayanan, R.
2013Research resource: Nuclear receptors as transcriptome: Discriminant and prognostic value in breast cancerMuscat, G.; Eriksson, N.; Byth, K.; Loi, S.; Graham, D.; Jindal, S.; Davis, M.; Clyne, C.; Funder, J.; Simpson, E.; Ragan, M.; Kuczek, E.; Fuller, P.; Tilley, W.; Leedman, P.; Clarke, C.
2011GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cellsChiam, K.; Centenera, M.; Butler, L.; Tilley, W.; Bianco-Miotto, T.; Agoulnik, I.
2012An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activityMoore, N.; Buchanan, G.; Harris, J.; Selth, L.; Bianco-Miotto, T.; Hanson, A.; Birrell, S.; Butler, L.; Hickey, T.; Tilley, W.
2012Protein arginine methyltransferase 6-dependent gene expression and splicing: association with breast cancer outcomesDowhan, D.; Harrison, M.; Eriksson, N.; Bailey, P.; Pearen, M.; Fuller, P.; Funder, J.; Simpson, E.; Leedman, P.; Tilley, W.; Brown, M.; Clarke, C.; Muscat, G.
2014PRMT2 and RORĪ³ expression are associated with breast cancer survival outcomesOh, T.; Bailey, P.; Dray, E.; Smith, A.; Goode, J.; Eriksson, N.; Funder, J.; Fuller, P.; Simpson, E.; Tilley, W.; Leedman, P.; Clarke, C.; Grimmond, S.; Dowhan, D.; Muscat, G.